Accessibility Menu
 
Cogstate logo

Cogstate

(ASX) CGS

Current Price$2.44
Market Cap$413.81M
Since IPO (2004)+403%
5 Year+180%
1 Year+82%
1 Month+12%

Cogstate Financials at a Glance

Market Cap

$413.81M

Revenue (TTM)

$149.43M

Net Income (TTM)

$25.93M

EPS (TTM)

$0.10

P/E Ratio

24.69

Dividend

$0.02

Beta (Volatility)

0.09 (Low)

Price

$2.44

Volume

112,092

Open

$2.42

Previous Close

$2.44

Daily Range

$2.41 - $2.47

52-Week Range

$1.21 - $2.97

CGS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cogstate

Industry

Health Care Technology

Employees

410

CEO

Bradley John O'Connor

Headquarters

Melbourne, VIC 3000, AU

CGS Financials

Key Financial Metrics (TTM)

Gross Margin

36%

Operating Margin

23%

Net Income Margin

20%

Return on Equity

23%

Return on Capital

30%

Return on Assets

21%

Earnings Yield

4.05%

Dividend Yield

0.01%

Payout Ratio

15.83%

Stock Overview

Market Cap

$413.81M

Shares Outstanding

170.99M

Volume

112.09K

Short Interest

0.00%

Avg. Volume

194.45K

Financials (TTM)

Gross Profit

$30.69M

Operating Income

$10.80M

EBITDA

$16.93M

Operating Cash Flow

$11.48M

Capital Expenditure

$3.07M

Free Cash Flow

$8.40M

Cash & ST Invst.

$35.56M

Total Debt

$638.90K

Cogstate Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$26.25M

-5.1%

Gross Profit

$7.26M

+101.8%

Gross Margin

27.66%

N/A

Market Cap

$413.81M

N/A

Market Cap/Employee

$2.82M

N/A

Employees

147

N/A

Net Income

$4.62M

+50.2%

EBITDA

$5.32M

-2.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$33.36M

-8.4%

Accounts Receivable

$13.72M

+13.6%

Inventory

$0.00

N/A

Long Term Debt

$602.17K

+26722.9%

Short Term Debt

$114.57K

-84.9%

Return on Assets

21.24%

N/A

Return on Invested Capital

29.73%

N/A

Free Cash Flow

$2.54M

+320.2%

Operating Cash Flow

$2.92M

+2637.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OCA.AXOceania Healthcare Limited
$0.57+0.00%
CUV.AXClinuvel Pharmaceuticals Limited
$9.04+2.61%
ACL.AXAustralian Clinical Labs Limited
$1.95-0.77%
AYA.AXArtrya Limited
$4.07+0.99%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.15+0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.18-0.09%
TQQQProShares Trust - ProShares UltraPro Qqq
$62.62+0.06%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$52.50-0.06%

Questions About CGS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.